PANDA - Prevention of Anaemia
Research type
Research Study
Full title
A phase III, multi-centre, randomised placebo-controlled trial of oral iron supplementation for the prevention of maternal anaemia
IRAS ID
1008549
Contact name
Simon Stanworth
Contact email
Sponsor organisation
NHS Blood and transplant
ISRCTN Number
ISRCTN16425597
Research summary
iron tablets is the main form of treatment of anaemia, but it is not known whether routine taking of iron, started early in pregnancy, to prevent anaemia, has clinical benefits for the mother and baby. Currently, there is no recommendation for taking of iron tablets and given the high burden of anaemia during later pregnancy, it is likely that many women develop low iron levels during pregnancy.
The trial research question is whether iron tablet taking using a low-dose given from early pregnancy (first booking clinic) will improve mother and baby outcomes, compared to a placebo (dummy table).
REC name
North of Scotland Research Ethics Committee 1
REC reference
23/NS/0123
Date of REC Opinion
17 Nov 2023
REC opinion
Further Information Favourable Opinion